Welcome to our dedicated page for Neuberger Berman High Yield Strategies Fund news (Ticker: NHS), a resource for investors and traders seeking the latest updates and insights on Neuberger Berman High Yield Strategies Fund stock.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) is a closed-end management investment company managed by Neuberger Berman, a prominent, employee-owned, private investment firm established in 1939. With a presence in 26 countries, the firm boasts over 2,800 professionals dedicated to delivering long-term investment results through active management, fundamental research, and engaged ownership.
The primary objective of the Fund is to invest the majority of its total assets in high yield debt securities, also known as junk bonds, from both U.S. and foreign issuers. This strategy aims to generate high income for its investors while managing the associated risks through diversified holdings.
The Fund has recently announced a series of monthly distributions of $0.0905 per share, adhering to a level distribution policy. These payments, expected to continue subject to market conditions, may consist of net investment income, realized capital gains, and return of capital. The Fund's ability to maintain these distributions depends on various factors, such as income stability from investments, leverage costs, and overall expenses.
Neuberger Berman, the investment manager for the Fund, manages a broad spectrum of strategies, including equity, fixed income, private equity, real estate, and hedge funds, catering to global institutions, advisors, and individual investors. The firm's commitment to environmental, social, and governance (ESG) factors has earned it the distinction of being a PRI Leader, an honor awarded to fewer than 1% of investment firms.
Highlighted for its exemplary workplace culture, Neuberger Berman has been named the top firm in Pensions & Investments' Best Places to Work in Money Management survey for ten consecutive years among firms with over 1,000 employees. As of March 31, 2024, the firm manages $474 billion in client assets.
For more detailed information, investors are encouraged to refer to the official notices and announcements distributed by the Fund, which include estimates of distribution sources and tax characteristics, ensuring transparency and compliance with regulatory requirements.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) has declared a monthly distribution of $0.0905 per share, payable on July 29, 2022. The record date is July 15, 2022 and the ex-date is July 14, 2022. The Fund aims to maintain this distribution amount, subject to market conditions, relying on income stability and expenses. Future distributions may include net investment income, capital gains, and return of capital. The Fund holds $447 billion in client assets as of March 31, 2022.
Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) has announced a successful private placement of $26.5 million through a Floating Rate Senior Note, maturing in September 2023. This action increases the Fund's leverage post a recent rights offering, which raised approximately $40.9 million by issuing 4,763,981 shares. The funds will be reinvested into portfolio securities aligned with the Fund's investment objectives.
Neuberger Berman High Yield Strategies Fund Inc. (NHS) has declared a monthly distribution of $0.0905 per share, payable on June 30, 2022, with a record date of June 15, 2022 and an ex-date of June 14, 2022. Following its stable distribution policy, the Fund plans to maintain this distribution amount, contingent on market conditions and investment income stability. Future distributions may include net investment income, capital gains, or return of capital, with specific tax characteristics determined at year-end.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) announced the final results of its rights offering that expired on May 17, 2022. The final subscription price was set at $8.60, equal to 87% of the Fund's net asset value per share on the expiration date. A total of 4,763,981 shares will be issued, generating gross proceeds of approximately $40.9 million. Shares are expected to be issued by May 25, 2022. Investors will receive refunds for any excess payments made during the offering.
Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) completed its transferable rights offering, which ran from April 19 to May 17, 2022. Each stockholder received one right per share held, requiring three rights to purchase additional shares at a final subscription price of $8.60, representing 87% of the share's net asset value. The offering is expected to result in approximately 4,811,400 shares issued and gross proceeds of $41.3 million. Final results will be announced later.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) announced the approval of a rights offering for its common stock, allowing shareholders to purchase additional shares at a discount. The record date is April 19, 2022, with an expiration date planned for May 17, 2022.
This initiative aims to enhance the Fund's assets for investment in non-investment-grade credit, potentially improving long-term returns, and is likely to maintain current distribution levels. The Offer is seen as a positive step to capitalize on market opportunities.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) has announced an early declaration for its regular monthly distribution of $0.0905 per share, payable on May 31, 2022. The record date is May 4, 2022 and the ex-date is May 3, 2022. The Fund aims to maintain this distribution level, dependent on factors such as income stability and expenses. Future distributions may include net investment income, capital gains, or return of capital. There are risks related to market performance and investment strategy that could impact future distributions.
Neuberger Berman High Yield Strategies Fund Inc. (NHS) declared a monthly distribution of $0.0905 per share, payable on April 29, 2022. The record date is April 18, 2022, with an ex-date of April 14, 2022. The Fund aims to maintain a stable distribution rate, which may consist of net investment income, capital gains, and return of capital. The ability to sustain this rate depends on income stability, leverage costs, and other fees. Risks include market declines and competition from other investment companies.
Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) declared a monthly distribution of $0.0905 per share, payable on March 31, 2022. The record date is March 15, 2022, and the ex-date is March 14, 2022. While the Fund aims to maintain this distribution level subject to market conditions, its ability to do so depends on income stability, leverage costs, and other fees. Future distributions may include net investment income, capital gains, and return of capital. The Fund manages $460 billion in assets as of December 31, 2021.
Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) declared a monthly distribution of $0.0905 per share, payable on February 28, 2022. The record date is February 15, 2022, with an ex-date of February 14, 2022. The fund aims to maintain a stable distribution policy, although future distributions may include net investment income, capital gains, or return of capital. The fund's ability to sustain this rate depends on income stability, leverage costs, and overall fees. Investors are cautioned that there is no guarantee of consistent distributions.
FAQ
What is the current stock price of Neuberger Berman High Yield Strategies Fund (NHS)?
What is the market cap of Neuberger Berman High Yield Strategies Fund (NHS)?
What is the primary investment objective of Neuberger Berman High Yield Strategies Fund Inc.?
How often does the Fund pay distributions?
What factors influence the Fund's ability to maintain its distribution rate?
Who manages Neuberger Berman High Yield Strategies Fund Inc.?
What types of strategies does Neuberger Berman manage?
What is Neuberger Berman's approach to investment management?
How many professionals are part of Neuberger Berman?
What recognition has Neuberger Berman received for its workplace culture?
What is the total client assets managed by Neuberger Berman?
How does the Fund ensure transparency in its distributions?
